Ontology highlight
ABSTRACT:
SUBMITTER: Clemens E
PROVIDER: S-EPMC7549756 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Clemens Eva E van den Heuvel-Eibrink Marry M MM Mulder Renée L RL Kremer Leontien C M LCM Hudson Melissa M MM Skinner Roderick R Constine Louis S LS Bass Johnnie K JK Kuehni Claudia E CE Langer Thorsten T van Dalen Elvira C EC Bardi Edith E Bonne Nicolas-Xavier NX Brock Penelope R PR Brooks Beth B Carleton Bruce B Caron Eric E Chang Kay W KW Johnston Karen K Knight Kristin K Nathan Paul C PC Orgel Etan E Prasad Pinki K PK Rottenberg Jan J Scheinemann Katrin K de Vries Andrica C H ACH Walwyn Thomas T Weiss Annette A Am Zehnhoff-Dinnesen Antoinette A Cohn Richard J RJ Landier Wendy W
The Lancet. Oncology 20190101 1
Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal care and reduce consequent problems-such as speech and language, social-emotional development, and learning difficulties-for these CAYA cancer survivors, clinical practice guidelines for monitoring ototoxicity are essential. The implementation of surveillance across clinical ...[more]